The Lifespan Respite Care Act’s purpose is threefold: expand and enhance respite care services to family caregivers; improve the statewide dissemination and coordination of respite care; and...more
ACL will fund up to 2 cooperative agreements with a federal funding level of up to $200,000 per award for a 36 month project period, pending the availability of Federal funds Eligible state agencies...more
The U.S. Administration for Community Living (ACL) is providing this competitive program expansion supplement opportunity to assist current FY 2014 Lifespan Respite Care Program—Building Long...more
ACL will fund up to 3 cooperative agreements with a federal funding level of up to $200,000 per award for a 36 month project period, pending the availability of Federal funds Eligible state agencies...more
ACL will fund one grant, with a federal funding level of up to $200,000 per award for a 36 month project period, pending the availability of Federal funds. Eligible state agencies funded under this...more
The U.S. Administration for Community Living (ACL) is providing this competitive grant opportunity to eligible entities for implementing the requirements of the Technical Assistance Resource Center...more
The Administration for Community Living (ACL) is providing this competitive grants opportunity to eligible state agencies for implementing the requirements of the Lifespan Respite Care Act of 2006...more
The Administration for Community Living (ACL) is providing this competitive grants opportunity to eligible state agencies to further implement and ensure the long-term sustainability of the...more
The Administration for Community Living (ACL)/U.S. Administration on Aging (AoA) is providing this competitive grants opportunity to eligible state agencies for implementing the requirements of the...more
SiMPACT ponders on the importance of data in philanthropy after an episode of the This American Life (#503 – I was Just Trying to Help), an episode which portrays an organization with a not-so conventional idea about charity.